| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| permethrin 5 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Boots covering cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Veil cover cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Dermablend cover cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Covermark classic foundation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| præparater til orofaryngal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Minor skin infection preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| slibemidler til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| kløestillende middel til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing ethyl-2-cyanoacrylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing 2-octyl cyanoacrylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| astringent og rensemiddel til lokal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| blødgørende, lindrende og beskyttende midler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Sclerosing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| adapalen 0,1 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| adapalen 0,1 % gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| teniposid 50 mg injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Zinksulfat 25 mg/5 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Tazarotene 0.1% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Selenium sulfide 25 mg/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Tazarotene 0.05% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumchlorid 250 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumsulfat 0,5 mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| trichloreddikesyre 80 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumsulfat 0,48 mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumsulfat 0,85 mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumsulfat 1,45 mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumsulfat 15 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumsulfat 25 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumsulfat 0,2 mg/10 mm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumsulfat 0,35 mg/10 mm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumsulfat 0,45 mg/10 mm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing precisely becaplermin 100 microgram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Zinksulfat 5mg/ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Teniposide 10mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumkaliumsulfat 0,138 mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumkaliumsulfat 0,244 mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumkaliumsulfat 0,68 mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumkaliumsulfat 0,28 mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Aluminium chloride 250 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| tretinoin 0,05 % væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing precisely tretinoin 200 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| trichloreddikesyre 15 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing precisely isotretinoin 10 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing precisely isotretinoin 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Calcipotriene hydrate 0.005% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Calcipotriene 0.005% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| cantharidin 0,7 % væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Calcipotriene 0.005% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Tretinoin 1 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Podofilox 0.5% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| podofilox 0,5 % gel til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| talcum-aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Benzyl penicilloyl-polylysin 0.06mmo injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Tretinoin 1 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Alitretinoin 0,1 % gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| monobenzon 20 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| chloroxylenol 1 mg + hydrocortison 10 mg + pramoxinhydrochlorid 10 mg dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing precisely mequinol 20 milligram/1 milliliter and tretinoin 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing isotretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing pimecrolimus (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Pimecrolimus 1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| benzoin- og salicylsyresalve |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Azelaic acid (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Chloroxylenol |
Causative agent |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Salicylic acid (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Dithranol |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Benzoic acid (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Podophyllum resin (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Hydroquinone (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Crotamiton (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| formeringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Tacrolimus monohydrate 0.03% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Tacrolimus monohydrate 0.1% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| tacrolimus til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Allantoin (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Enbucrilate |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| cellestimulerende middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| depigmenterende middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| kortikosteroid til lokal anvendelse, gruppe III |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing benzyl benzoate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Tar-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing sodium tetradecyl sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| astringerende middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing coal tar (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| hudmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing aluminium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| kortikosteroid til topikal anvendelse, gruppe VI |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing teniposide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Sodium tetradecyl |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| kortikosteroid til topikal anvendelse , gruppe I |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| kortikosteroid til topikal anvendelse, gruppe IV |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| antiinflammatorisk hudmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| tjærer og balsamer |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Bufexamac (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Selenium |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Bromine |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Antiinfektiøst middel til huden |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
FHIR